Invention Grant
- Patent Title: Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
-
Application No.: US15289629Application Date: 2016-10-10
-
Publication No.: US09809548B2Publication Date: 2017-11-07
- Inventor: Joanna Bis , David H. Igo
- Applicant: ChemoCentryx, Inc.
- Applicant Address: US CA Mountain View
- Assignee: ChemoCentryx, Inc.
- Current Assignee: ChemoCentryx, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Brinks Gilson & Lione
- Agent Ryan L. Marshall
- Main IPC: C07D211/82
- IPC: C07D211/82 ; C07D213/89 ; A61K31/44 ; A61K31/4425 ; A61K45/06
![Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide](/abs-image/US/2017/11/07/US09809548B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are novel polymorphic solvated and desolvated forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)phenyl]-benzenesulfonamide. One embodiment of the present invention is directed to a crystalline sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]benzenesulfonamide (hereinafter “Compound A-1,4-dioxane/water solvate”), wherein the crystalline form is characterized by an X-ray powder diffraction pattern comprising diffraction angles (°28), when measured using Cu Ku radiation, at about 4.0, 8.1, 10.1, 14.2, 16.2, 18.6, 20.3, 24.7, 25.0, and 26.5.
Public/Granted literature
Information query